[
  {
    "ts": null,
    "headline": "Nasdaq, S&P 500 Clinch Records Amid Fresh Economic Data, Earnings Reports",
    "summary": "The Nasdaq Composite and the S&P 500 climbed to new highs on Thursday as Wall Street tracked the lat",
    "url": "https://finnhub.io/api/news?id=4b8334a41fb9cdf742045d8030d89893447b784d2ee2cae21efa2de4b8fae2a1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752786596,
      "headline": "Nasdaq, S&P 500 Clinch Records Amid Fresh Economic Data, Earnings Reports",
      "id": 136005572,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The Nasdaq Composite and the S&P 500 climbed to new highs on Thursday as Wall Street tracked the lat",
      "url": "https://finnhub.io/api/news?id=4b8334a41fb9cdf742045d8030d89893447b784d2ee2cae21efa2de4b8fae2a1"
    }
  },
  {
    "ts": null,
    "headline": "These Stocks Moved the Most Today: Lucid, TSMC, Elevance, Sarepta, PepsiCo, Abbott Labs, Archer Daniels, and More",
    "summary": "Lucid soars after announcing a self-driving partnership with Uber Technologies and Nuro, Taiwan Semiconductor Manufacturing reports a record profit in the second quarter, and PepsiCo’s adjusted earnings top forecasts.",
    "url": "https://finnhub.io/api/news?id=500a4d3875fc24c94e6396657ccc030d6a2b2fd48b77efb2ce60f1af9501a7e9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752784680,
      "headline": "These Stocks Moved the Most Today: Lucid, TSMC, Elevance, Sarepta, PepsiCo, Abbott Labs, Archer Daniels, and More",
      "id": 136005574,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Lucid soars after announcing a self-driving partnership with Uber Technologies and Nuro, Taiwan Semiconductor Manufacturing reports a record profit in the second quarter, and PepsiCo’s adjusted earnings top forecasts.",
      "url": "https://finnhub.io/api/news?id=500a4d3875fc24c94e6396657ccc030d6a2b2fd48b77efb2ce60f1af9501a7e9"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories Sheds 8% On A Rare Guidance Miss",
    "summary": "Abbott stock toppled Thursday after the health giant issued a light organic sales outlook for 2025, though it beat quarterly estimates.",
    "url": "https://finnhub.io/api/news?id=168fdc2dd695f9e7a0fde94b1a1d8ceb298d802defa2317c5faa739704bb5425",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752783052,
      "headline": "Abbott Laboratories Sheds 8% On A Rare Guidance Miss",
      "id": 136005575,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott stock toppled Thursday after the health giant issued a light organic sales outlook for 2025, though it beat quarterly estimates.",
      "url": "https://finnhub.io/api/news?id=168fdc2dd695f9e7a0fde94b1a1d8ceb298d802defa2317c5faa739704bb5425"
    }
  },
  {
    "ts": null,
    "headline": "Equities Rise Intraday as Markets Parse Macro Data, Earnings",
    "summary": "US benchmark equity indexes were higher intraday as traders assessed the latest corporate earnings a",
    "url": "https://finnhub.io/api/news?id=c72427121060fd9509c448570cd859f19cc3b8a533f0d3f8e9779bcc0f7e259f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752774244,
      "headline": "Equities Rise Intraday as Markets Parse Macro Data, Earnings",
      "id": 135996813,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "US benchmark equity indexes were higher intraday as traders assessed the latest corporate earnings a",
      "url": "https://finnhub.io/api/news?id=c72427121060fd9509c448570cd859f19cc3b8a533f0d3f8e9779bcc0f7e259f"
    }
  },
  {
    "ts": null,
    "headline": "Health Care Declines as Abbott Labs, Elevance Slide on Earnings - Health Care Roundup",
    "summary": "Health Care Declines as Abbott Labs, Elevance Slide on Earnings - Health Care Roundup",
    "url": "https://finnhub.io/api/news?id=1a18147d75aa248e7bcd7a883663f7453f93314a3fc4aa5cb4283b316a21294f",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752772980,
      "headline": "Health Care Declines as Abbott Labs, Elevance Slide on Earnings - Health Care Roundup",
      "id": 136002565,
      "image": "",
      "related": "ABT",
      "source": "MarketWatch",
      "summary": "Health Care Declines as Abbott Labs, Elevance Slide on Earnings - Health Care Roundup",
      "url": "https://finnhub.io/api/news?id=1a18147d75aa248e7bcd7a883663f7453f93314a3fc4aa5cb4283b316a21294f"
    }
  },
  {
    "ts": null,
    "headline": "Why Abbott Laboratories (ABT) Shares Are Plunging Today",
    "summary": "Shares of healthcare product and device company Abbott Laboratories (NYSE:ABT) fell 8.1% in the afternoon session after the company reported second-quarter earnings that beat analyst expectations but maintained its full-year guidance, which may have disappointed investors hoping for a raised outlook.",
    "url": "https://finnhub.io/api/news?id=0e4aea9a34c6e865eec12ddb8617f7d4380c59d274406acf24d42a537406606e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752772870,
      "headline": "Why Abbott Laboratories (ABT) Shares Are Plunging Today",
      "id": 135996859,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Shares of healthcare product and device company Abbott Laboratories (NYSE:ABT) fell 8.1% in the afternoon session after the company reported second-quarter earnings that beat analyst expectations but maintained its full-year guidance, which may have disappointed investors hoping for a raised outlook.",
      "url": "https://finnhub.io/api/news?id=0e4aea9a34c6e865eec12ddb8617f7d4380c59d274406acf24d42a537406606e"
    }
  },
  {
    "ts": null,
    "headline": "Biochip Market Global Outlook Report 2025, with Focus on Microarrays and Lab-on-a-Chip",
    "summary": "Discover comprehensive insights into the global biochip market, providing revenue analysis, trends, and forecasts to 2029. Examine segmented data by product type, technology, application, and region, and explore sustainability, ESG developments, and key players like Abbott and Agilent Technologies. Global Biochip Market Market Global Biochip Market Market Dublin, July 17, 2025 (GLOBE NEWSWIRE) -- The \"Biochip Market: Microarrays and Lab-on-a-Chip\" report has been added to ResearchAndMarkets.com'",
    "url": "https://finnhub.io/api/news?id=ba0621b5f1f84d0e56888166608956fab7444804f8ef91c08104c23ef99c7685",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752771540,
      "headline": "Biochip Market Global Outlook Report 2025, with Focus on Microarrays and Lab-on-a-Chip",
      "id": 135994396,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Discover comprehensive insights into the global biochip market, providing revenue analysis, trends, and forecasts to 2029. Examine segmented data by product type, technology, application, and region, and explore sustainability, ESG developments, and key players like Abbott and Agilent Technologies. Global Biochip Market Market Global Biochip Market Market Dublin, July 17, 2025 (GLOBE NEWSWIRE) -- The \"Biochip Market: Microarrays and Lab-on-a-Chip\" report has been added to ResearchAndMarkets.com'",
      "url": "https://finnhub.io/api/news?id=ba0621b5f1f84d0e56888166608956fab7444804f8ef91c08104c23ef99c7685"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories stock underperforms Thursday when compared to competitors",
    "summary": "Abbott Laboratories stock underperforms Thursday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=992d6e7165fea80f29092cc7ef15959de488b1e0864dbf72141a55142b0beb86",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752769800,
      "headline": "Abbott Laboratories stock underperforms Thursday when compared to competitors",
      "id": 136002566,
      "image": "",
      "related": "ABT",
      "source": "MarketWatch",
      "summary": "Abbott Laboratories stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=992d6e7165fea80f29092cc7ef15959de488b1e0864dbf72141a55142b0beb86"
    }
  },
  {
    "ts": null,
    "headline": "Top Midday Stories: TSMC Lifts 2025 Revenue Growth Guidance; Lucid Partners With Uber on Robotaxi Launch",
    "summary": "All three major US stock indexes were up in late-morning trading Thursday as fresh economic data and",
    "url": "https://finnhub.io/api/news?id=d94db17994f9a835e43ce79d35c3f465634ade5cf28b9e162952cbadd8ccede4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752768222,
      "headline": "Top Midday Stories: TSMC Lifts 2025 Revenue Growth Guidance; Lucid Partners With Uber on Robotaxi Launch",
      "id": 135993315,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "All three major US stock indexes were up in late-morning trading Thursday as fresh economic data and",
      "url": "https://finnhub.io/api/news?id=d94db17994f9a835e43ce79d35c3f465634ade5cf28b9e162952cbadd8ccede4"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Earnings Beat Forecasts. Why the Stock Is Having Its Worst Day Since 2021.",
    "summary": "Abbott Laboratories stock falls even as the company reports second-quarter sales that top expectations.",
    "url": "https://finnhub.io/api/news?id=c02bea75103cfc61789776d99b0ef876a358486adf4824b105deb17f4156d997",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752766140,
      "headline": "Abbott Earnings Beat Forecasts. Why the Stock Is Having Its Worst Day Since 2021.",
      "id": 135993316,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott Laboratories stock falls even as the company reports second-quarter sales that top expectations.",
      "url": "https://finnhub.io/api/news?id=c02bea75103cfc61789776d99b0ef876a358486adf4824b105deb17f4156d997"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Narrows Its Outlook as COVID-19 Testing Demand Wanes. Its Stock Is Falling.",
    "summary": "Abbott Laboratories shares slumped Thursday after the drugmaker narrowed its full-year outlook, even as it posted better-than-expected quarterly results, as demand for COVID-19 tests declines.",
    "url": "https://finnhub.io/api/news?id=3ad768c6272f3f7266ee906d9e3e7bc8c8a912f01442b44a2a1ecefae8753b71",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752765194,
      "headline": "Abbott Narrows Its Outlook as COVID-19 Testing Demand Wanes. Its Stock Is Falling.",
      "id": 135993317,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott Laboratories shares slumped Thursday after the drugmaker narrowed its full-year outlook, even as it posted better-than-expected quarterly results, as demand for COVID-19 tests declines.",
      "url": "https://finnhub.io/api/news?id=3ad768c6272f3f7266ee906d9e3e7bc8c8a912f01442b44a2a1ecefae8753b71"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Stock Falls in Pre-Market Despite Q2 Earnings and Sales Beat",
    "summary": "ABT beats on Q2 earnings and revenues with double-digit growth in Medical Devices, yet shares fall 5% pre-market.",
    "url": "https://finnhub.io/api/news?id=0dc111b77d7073683a541852a6d072d7bcc69d839e4692de4cf8467fb0539556",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752764760,
      "headline": "Abbott Stock Falls in Pre-Market Despite Q2 Earnings and Sales Beat",
      "id": 135995650,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "ABT beats on Q2 earnings and revenues with double-digit growth in Medical Devices, yet shares fall 5% pre-market.",
      "url": "https://finnhub.io/api/news?id=0dc111b77d7073683a541852a6d072d7bcc69d839e4692de4cf8467fb0539556"
    }
  },
  {
    "ts": null,
    "headline": "These Stocks Are Moving the Most Today: Lucid, TSMC, United, Sarepta, PepsiCo, Abbott Labs, MP Materials, Archer Daniels, and More",
    "summary": "Lucid soars after announcing a self-driving partnership with Uber Technologies and Nuro, Taiwan Semiconductor Manufacturing reports a record profit in the second quarter, and PepsiCo’s adjusted earnings top forecasts.",
    "url": "https://finnhub.io/api/news?id=d95bdf9f638200b3c9b9aff8c841550674f8d650a9dad3e287ff6c688ad5d954",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752764280,
      "headline": "These Stocks Are Moving the Most Today: Lucid, TSMC, United, Sarepta, PepsiCo, Abbott Labs, MP Materials, Archer Daniels, and More",
      "id": 135993051,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Lucid soars after announcing a self-driving partnership with Uber Technologies and Nuro, Taiwan Semiconductor Manufacturing reports a record profit in the second quarter, and PepsiCo’s adjusted earnings top forecasts.",
      "url": "https://finnhub.io/api/news?id=d95bdf9f638200b3c9b9aff8c841550674f8d650a9dad3e287ff6c688ad5d954"
    }
  },
  {
    "ts": null,
    "headline": "Eased Tariff Impact Fails To Lift Abbott As Outlook Cut Disappoints Investors",
    "summary": "Abbott Laboratories (NYSE:ABT) reported better-than-expected sales and profits in the second quarter, but the stock still plummeted nearly 10% after management dialed back earnings and growth projections for the rest of the year. The company reported second-quarter sales of $11.14 billion, beating the consensus of $11.07 billion. Second-quarter sales increased 7.4% on a reported basis, 6.9% on an organic basis, or 7.5% when excluding COVID-19 testing-related sales. Also Read: Elevance Health Hit",
    "url": "https://finnhub.io/api/news?id=c7eaac1daee4f84c54d763ff7be08bc085eec641be7948ff264d1c2e16b74082",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752763695,
      "headline": "Eased Tariff Impact Fails To Lift Abbott As Outlook Cut Disappoints Investors",
      "id": 135993319,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott Laboratories (NYSE:ABT) reported better-than-expected sales and profits in the second quarter, but the stock still plummeted nearly 10% after management dialed back earnings and growth projections for the rest of the year. The company reported second-quarter sales of $11.14 billion, beating the consensus of $11.07 billion. Second-quarter sales increased 7.4% on a reported basis, 6.9% on an organic basis, or 7.5% when excluding COVID-19 testing-related sales. Also Read: Elevance Health Hit",
      "url": "https://finnhub.io/api/news?id=c7eaac1daee4f84c54d763ff7be08bc085eec641be7948ff264d1c2e16b74082"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Issues Downbeat Third-Quarter Earnings Outlook; Narrows Full-Year Profit Guidance",
    "summary": "Abbott Laboratories (ABT) issued a third-quarter earnings outlook below market estimates on Thursday",
    "url": "https://finnhub.io/api/news?id=56463207a51262f6db5db09965eafb8d80296d05e85fa768ab500cbfe5af84f1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752762808,
      "headline": "Abbott Issues Downbeat Third-Quarter Earnings Outlook; Narrows Full-Year Profit Guidance",
      "id": 135993320,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott Laboratories (ABT) issued a third-quarter earnings outlook below market estimates on Thursday",
      "url": "https://finnhub.io/api/news?id=56463207a51262f6db5db09965eafb8d80296d05e85fa768ab500cbfe5af84f1"
    }
  },
  {
    "ts": null,
    "headline": "GE Aerospace, Abbott Labs, Elevance: Trending Tickers",
    "summary": "GE Aerospace (GE) stock pops after reporting a strong second quarter and raising its full-year outlook. Abbott Laboratories (ABT) narrows its full-year outlook despite in-line earnings as Trump threatens tariffs on the pharmaceutical industry. Elevance (ELV) lowers its full-year profit outlook as higher costs associated with changing government plans weigh on insurers. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",
    "url": "https://finnhub.io/api/news?id=7ead06b29abd5c0aa337a37d1150a4e5d7e76ad3fb0d9a7479e6a73a6ec2acb4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752761462,
      "headline": "GE Aerospace, Abbott Labs, Elevance: Trending Tickers",
      "id": 135993207,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "GE Aerospace (GE) stock pops after reporting a strong second quarter and raising its full-year outlook. Abbott Laboratories (ABT) narrows its full-year outlook despite in-line earnings as Trump threatens tariffs on the pharmaceutical industry. Elevance (ELV) lowers its full-year profit outlook as higher costs associated with changing government plans weigh on insurers. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",
      "url": "https://finnhub.io/api/news?id=7ead06b29abd5c0aa337a37d1150a4e5d7e76ad3fb0d9a7479e6a73a6ec2acb4"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories (ABT) Q2 2025 Earnings Call Transcript",
    "summary": "Abbott Laboratories (NYSE:ABT) Q2 2025 Results Conference Call July 17, 2025 9:00 AM ETCompany ParticipantsMichael Comilla - Vice President of Investor...",
    "url": "https://finnhub.io/api/news?id=5fbafec4ad432ee6f5d3e31eb3a238cd99332d54e430d4619d494cc800f319a5",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752761100,
      "headline": "Abbott Laboratories (ABT) Q2 2025 Earnings Call Transcript",
      "id": 135996369,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "ABT",
      "source": "SeekingAlpha",
      "summary": "Abbott Laboratories (NYSE:ABT) Q2 2025 Results Conference Call July 17, 2025 9:00 AM ETCompany ParticipantsMichael Comilla - Vice President of Investor...",
      "url": "https://finnhub.io/api/news?id=5fbafec4ad432ee6f5d3e31eb3a238cd99332d54e430d4619d494cc800f319a5"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories Sheds Nearly 6% On A Rare Guidance Miss",
    "summary": "Abbott stock toppled early Thursday after the health giant issued a light organic sales outlook for 2025, though it beat quarterly estimates.",
    "url": "https://finnhub.io/api/news?id=cfa3bcf9cb9ed5981975dde8bde35c48e884d24b1ab8c49578556a87681ab85a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752760906,
      "headline": "Abbott Laboratories Sheds Nearly 6% On A Rare Guidance Miss",
      "id": 135993322,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott stock toppled early Thursday after the health giant issued a light organic sales outlook for 2025, though it beat quarterly estimates.",
      "url": "https://finnhub.io/api/news?id=cfa3bcf9cb9ed5981975dde8bde35c48e884d24b1ab8c49578556a87681ab85a"
    }
  },
  {
    "ts": null,
    "headline": "Abbott (ABT) Reports Q2 Earnings: What Key Metrics Have to Say",
    "summary": "Although the revenue and EPS for Abbott (ABT) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
    "url": "https://finnhub.io/api/news?id=8a596fe861371548930cb8d2eef28ece7aeac27df4dbdaeb6d9e0bb1c7ca30ce",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752759003,
      "headline": "Abbott (ABT) Reports Q2 Earnings: What Key Metrics Have to Say",
      "id": 135993323,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Although the revenue and EPS for Abbott (ABT) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
      "url": "https://finnhub.io/api/news?id=8a596fe861371548930cb8d2eef28ece7aeac27df4dbdaeb6d9e0bb1c7ca30ce"
    }
  },
  {
    "ts": null,
    "headline": "Abbott (ABT) Q2 Earnings and Revenues Top Estimates",
    "summary": "Abbott (ABT) delivered earnings and revenue surprises of +0.80% and +0.63%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=cdbfc1ec4445b4456654f5f40018c884aafac20a46725b79871904c2e273218d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752756001,
      "headline": "Abbott (ABT) Q2 Earnings and Revenues Top Estimates",
      "id": 135993324,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott (ABT) delivered earnings and revenue surprises of +0.80% and +0.63%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=cdbfc1ec4445b4456654f5f40018c884aafac20a46725b79871904c2e273218d"
    }
  },
  {
    "ts": null,
    "headline": "Abbott’s Q2 revenue tops expectations but shares fall",
    "summary": "Investing.com -- Abbott Laboratories reported second-quarter earnings that slightly exceeded analyst expectations, but shares fell 2.5% following the results.",
    "url": "https://finnhub.io/api/news?id=93e8f4bbb266740b364478c644199d92eb30d1f68c3e55cfa8e0c14795028b0b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752754405,
      "headline": "Abbott’s Q2 revenue tops expectations but shares fall",
      "id": 135993325,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Investing.com -- Abbott Laboratories reported second-quarter earnings that slightly exceeded analyst expectations, but shares fell 2.5% following the results.",
      "url": "https://finnhub.io/api/news?id=93e8f4bbb266740b364478c644199d92eb30d1f68c3e55cfa8e0c14795028b0b"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Labs Pares Outlook After Profit, Sales Gains",
    "summary": "The healthcare-products maker trimmed and narrowed its guidance for the year while reporting strong profit and sales gains in the second quarter.",
    "url": "https://finnhub.io/api/news?id=5e5c179749c3a247a806dfe3441c06f72c25b2e17bb3974b76014b0922ebdac6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752753900,
      "headline": "Abbott Labs Pares Outlook After Profit, Sales Gains",
      "id": 135993326,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The healthcare-products maker trimmed and narrowed its guidance for the year while reporting strong profit and sales gains in the second quarter.",
      "url": "https://finnhub.io/api/news?id=5e5c179749c3a247a806dfe3441c06f72c25b2e17bb3974b76014b0922ebdac6"
    }
  },
  {
    "ts": null,
    "headline": "Abbott lowers sales forecast on diagnostics decline, US funding cuts",
    "summary": "Medical device sales remained a bright spot for the company, however, with more than 20% growth in diabetes devices.",
    "url": "https://finnhub.io/api/news?id=51ee835267e09e283dde8201a1851c883b63f4fab0074b85d781acda4e82d7a6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752753108,
      "headline": "Abbott lowers sales forecast on diagnostics decline, US funding cuts",
      "id": 135993327,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Medical device sales remained a bright spot for the company, however, with more than 20% growth in diabetes devices.",
      "url": "https://finnhub.io/api/news?id=51ee835267e09e283dde8201a1851c883b63f4fab0074b85d781acda4e82d7a6"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories’s (NYSE:ABT) Q2 Sales Top Estimates",
    "summary": "Healthcare product and device company Abbott Laboratories (NYSE:ABT) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 7.4% year on year to $11.14 billion. Its non-GAAP profit of $1.26 per share was in line with analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=d674f5899396c6a11edc3f8a6a50f74f6775ca466a7ac2365426f99c31742879",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752752687,
      "headline": "Abbott Laboratories’s (NYSE:ABT) Q2 Sales Top Estimates",
      "id": 135993328,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Healthcare product and device company Abbott Laboratories (NYSE:ABT) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 7.4% year on year to $11.14 billion. Its non-GAAP profit of $1.26 per share was in line with analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=d674f5899396c6a11edc3f8a6a50f74f6775ca466a7ac2365426f99c31742879"
    }
  },
  {
    "ts": null,
    "headline": "Abbott: Q2 Earnings Snapshot",
    "summary": "The results surpassed Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of $1.25 per share. The maker of infant formula, medical devices and drugs posted revenue of $11.14 billion in the period, which also beat Street forecasts.",
    "url": "https://finnhub.io/api/news?id=15dcc58a649b5cda68e78f0064d6601406efe2ba1cae670e9d32aad6a80e9637",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752752267,
      "headline": "Abbott: Q2 Earnings Snapshot",
      "id": 135993329,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The results surpassed Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of $1.25 per share. The maker of infant formula, medical devices and drugs posted revenue of $11.14 billion in the period, which also beat Street forecasts.",
      "url": "https://finnhub.io/api/news?id=15dcc58a649b5cda68e78f0064d6601406efe2ba1cae670e9d32aad6a80e9637"
    }
  },
  {
    "ts": null,
    "headline": "Abbott profit forecast falls short, ramps up US investing amid tariff pressure",
    "summary": "(Reuters) -Abbott on Thursday forecast third-quarter profit below Wall Street expectations and estimated about $200 million in annual tariff costs.  The medical device maker's shares slid 8%, even as it announced a new plant in the U.S. to mitigate the hit from President Donald Trump's sweeping duties on trading partners.  Speaking on a post-earnings call, Chief Financial Officer Phil Boudreau said the impact of tariffs will likely be felt in the second half of the year, as the company works its way through its inventory.",
    "url": "https://finnhub.io/api/news?id=a4de5337344f875174f84c5e34924642ed1bcd17f5d60310550a257ed5d5cef4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752752029,
      "headline": "Abbott profit forecast falls short, ramps up US investing amid tariff pressure",
      "id": 135993139,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "(Reuters) -Abbott on Thursday forecast third-quarter profit below Wall Street expectations and estimated about $200 million in annual tariff costs.  The medical device maker's shares slid 8%, even as it announced a new plant in the U.S. to mitigate the hit from President Donald Trump's sweeping duties on trading partners.  Speaking on a post-earnings call, Chief Financial Officer Phil Boudreau said the impact of tariffs will likely be felt in the second half of the year, as the company works its way through its inventory.",
      "url": "https://finnhub.io/api/news?id=a4de5337344f875174f84c5e34924642ed1bcd17f5d60310550a257ed5d5cef4"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Reports Second-Quarter 2025 Results",
    "summary": "Abbott (NYSE: ABT) today announced financial results for the second quarter ended June 30, 2025.",
    "url": "https://finnhub.io/api/news?id=f2f61a6e8c2135d785b5b6d9965c110e146dd6202da867de0f5b41309dc73899",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752751800,
      "headline": "Abbott Reports Second-Quarter 2025 Results",
      "id": 135993331,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott (NYSE: ABT) today announced financial results for the second quarter ended June 30, 2025.",
      "url": "https://finnhub.io/api/news?id=f2f61a6e8c2135d785b5b6d9965c110e146dd6202da867de0f5b41309dc73899"
    }
  },
  {
    "ts": null,
    "headline": "Stocks Mostly Up Pre-Bell as Trump Denies Speculation About Firing Fed Chair Powell; Corporate Earnings on Deck",
    "summary": "US equity markets were mostly pointing higher before the opening bell Thursday as President Donald T",
    "url": "https://finnhub.io/api/news?id=48cc68a1407043d02a2ccc15fed73754c7b8746b2f0f00d29d2daa5b3c7248c2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752751617,
      "headline": "Stocks Mostly Up Pre-Bell as Trump Denies Speculation About Firing Fed Chair Powell; Corporate Earnings on Deck",
      "id": 135993055,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "US equity markets were mostly pointing higher before the opening bell Thursday as President Donald T",
      "url": "https://finnhub.io/api/news?id=48cc68a1407043d02a2ccc15fed73754c7b8746b2f0f00d29d2daa5b3c7248c2"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories (NYSE:ABT) Has A Rock Solid Balance Sheet",
    "summary": "Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...",
    "url": "https://finnhub.io/api/news?id=25e5db7a5abeb5c7d5cdb1163387bee342568bf3e752858ac6433457c788c2f8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752750013,
      "headline": "Abbott Laboratories (NYSE:ABT) Has A Rock Solid Balance Sheet",
      "id": 135993333,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...",
      "url": "https://finnhub.io/api/news?id=25e5db7a5abeb5c7d5cdb1163387bee342568bf3e752858ac6433457c788c2f8"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Labs: Q2 EPS up 10%",
    "summary": "Abbott Laboratories has reported Q2 2025 adjusted EPS that is up over 10% to $1.26, actually missing the consensus, with an adjusted operating margin of 22.9%, up 100bp.At over $11.1bn, the healthcare...",
    "url": "https://finnhub.io/api/news?id=dec5fa2f4a1275620f563f52a46b8014a68cc29fc6666da8142a7b81bff33b2f",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752742624,
      "headline": "Abbott Labs: Q2 EPS up 10%",
      "id": 135992305,
      "image": "",
      "related": "ABT",
      "source": "Finnhub",
      "summary": "Abbott Laboratories has reported Q2 2025 adjusted EPS that is up over 10% to $1.26, actually missing the consensus, with an adjusted operating margin of 22.9%, up 100bp.At over $11.1bn, the healthcare...",
      "url": "https://finnhub.io/api/news?id=dec5fa2f4a1275620f563f52a46b8014a68cc29fc6666da8142a7b81bff33b2f"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Labs Pares Outlook, Logs 2Q Profit Gains",
    "summary": "Abbott Labs Pares Outlook, Logs 2Q Profit Gains",
    "url": "https://finnhub.io/api/news?id=d47a5e086bd90bcb154bc7ebb471b27268d3621cc767ec0c55cf8d70a9bbe87f",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752738900,
      "headline": "Abbott Labs Pares Outlook, Logs 2Q Profit Gains",
      "id": 136002568,
      "image": "",
      "related": "ABT",
      "source": "MarketWatch",
      "summary": "Abbott Labs Pares Outlook, Logs 2Q Profit Gains",
      "url": "https://finnhub.io/api/news?id=d47a5e086bd90bcb154bc7ebb471b27268d3621cc767ec0c55cf8d70a9bbe87f"
    }
  },
  {
    "ts": null,
    "headline": "Netflix Earnings, Consumer Sentiment, Retail Sales: Still to Come This Week",
    "summary": "The earnings calendar turns to big consumer names, after banks provided the highlights earlier this week. GE Aerospace, PepsiCo and Netflix are among companies reporting results Thursday, in the first big week of earnings season.",
    "url": "https://finnhub.io/api/news?id=343d09ee7c3b43baa6570b8acad89869f9c92ce6a73b5c2592dfbe0634d4597e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752738387,
      "headline": "Netflix Earnings, Consumer Sentiment, Retail Sales: Still to Come This Week",
      "id": 135993334,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The earnings calendar turns to big consumer names, after banks provided the highlights earlier this week. GE Aerospace, PepsiCo and Netflix are among companies reporting results Thursday, in the first big week of earnings season.",
      "url": "https://finnhub.io/api/news?id=343d09ee7c3b43baa6570b8acad89869f9c92ce6a73b5c2592dfbe0634d4597e"
    }
  }
]